• Precision BioSciences to Participate in Upcoming Jefferies Cell & Genetic Medicine Summit

    14 days ago - By Precision Biosciences

    DURHAM, N.C. --Sep. 22, 2022- Precision BioSciences, Inc. a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that the Company will participate in the Jefferies Cell & Genetic
    Read more ...

     

  • Wugen to Present at the Upcoming Jefferies Cell & Genetic Medicine Summit

    14 days ago - By San Diego Biotechnology

    ST. LOUIS & SAN DIEGO--Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced that management will participate...
    Read more ...